Acupuncture therapy in reducing high blood pressure
Not Applicable
Withdrawn
- Conditions
- Hypertension
- Registration Number
- SLCTR/2017/029
- Lead Sponsor
- Ministry of Health, Government of Nepal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
1. Men and women aged 30 - 70 years.
2. Participants who meet the diagnostic criteria of hypertension according to the International society of Hypertension Guidelines, 2013
Exclusion Criteria
Participants diagnosed with disorders in heart, kidney, thyroid gland, diabetes, neurological disease, skin or bleeding disorders and currently on any drugs or medications for any other chronic disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie acupuncture's antihypertensive effects in essential hypertension?
How does acupuncture compare to ACE inhibitors in managing essential hypertension in Nepal?
Are there specific biomarkers that predict response to acupuncture in essential hypertension patients?
What adverse events are associated with acupuncture therapy for essential hypertension and how are they managed?
What combination therapies with acupuncture show promise in reducing essential hypertension compared to monotherapy?